List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 599 studies with search of: Testosterone OR Androgel, Testoderm, Androderm, Depo-Testosterone[TREATMENT] AND HIV [CONDITION]
Hide studies that are not seeking new volunteers.
Hide studies with unknown recruitment status.
  Display Options
Rank Status Study
1 Completed Testosterone for HIV-Positive Men With Reduced Serum Testosterone Levels and Abdominal Fat
Condition: HIV Infections
Intervention: Drug: Testosterone
2 Completed A Study of Megestrol Acetate Alone or in Combination With Testosterone Enanthate Drug in the Treatment of HIV-Associated Weight Loss
Conditions: HIV Infections;   HIV Wasting Syndrome
Interventions: Drug: Testosterone enanthate;   Drug: Megestrol acetate
3 Completed AIDS Wasting in Women: Anabolic Effects of Testosterone
Condition: AIDS Wasting Syndrome
Intervention: Drug: Testosterone
4 Completed Testosterone and Physical Function in HIV+ Men
Condition: HIV Associate Weight Loss
Intervention: Drug: testosterone enanthate
5 Unknown † Phase II Randomized Study of Physiologic Testosterone Replacement in Premenopausal, HIV-Positive Women
Conditions: HIV Infections;   Cachexia
Intervention: Drug: testosterone
6 Active, not recruiting The Effect on Androxal Versus Androgel on Morning Testosterone in Men With Secondary Hypogonadism (Low Testosterone)
Conditions: Hypogonadism;   Low Testosterone
Interventions: Drug: enclomiophene citrate;   Drug: Testosterone
7 Recruiting Anabolic and Inflammatory Responses to Short-Term Testosterone Administration in Older Men
Condition: Sarcopenia
Interventions: Drug: Testosterone injection;   Drug: Testosterone gel
8 Active, not recruiting Exogenous Testosterone Plus Dutasteride for the Treatment of Castrate Metastatic Prostate Cancer
Conditions: Prostate Cancer;   Castration-resistant, Metastatic
Intervention: Other: testosterone (AndroGel®) with the 5α-reductase inhibitor dutasteride
9 Enrolling by invitation A One Year Open Label Study for the Treatment of Hypogonadism (Low Testosterone) in Men Who Have Completed ZA-203
Conditions: Hypogonadism;   Low Testosterone
Interventions: Drug: Androxal (enclomiphene citrate);   Drug: Testim (topical testosterone)
10 Active, not recruiting Normalization of Morning Testosterone Levels in Men With Secondary Hypogonadism (Low Testosterone), That Wish to Maintain Their Reproductive Status
Conditions: Secondary Hypogonadism;   Preservation of Reproductive Status
Interventions: Drug: Placebo;   Drug: topical testosterone;   Drug: enclomiphene citrate
11 Recruiting Testosterone for Penile Rehab After Radical Prostatectomy
Conditions: Low Testosterone Levels;   Erectile Dysfunction
Interventions: Drug: Testim® + Viagra®;   Drug: Placebo Testim® + Viagra®
12 Recruiting Neuroendocrine Dysfunction in Traumatic Brain Injury: Effects of Testosterone Therapy
Conditions: Testosterone;   Trauma;   Brain Injury
Interventions: Drug: Androgel (Testosterone Gel);   Drug: Androgel Placebo
13 Completed Co-Administering Testosterone With PDE5 Inhibitors in ED Patients Non Responders to PDE5 Inhibitors Alone
Conditions: Erectile Dysfunction;   Hypogonadism
Interventions: Drug: Testosterone gel;   Drug: testosterone;   Other: placebo gel
14 Recruiting Effect of Androgel on Type 2 Diabetic Males With Hypogonadism
Condition: Diabetes Mellitus Type 2
Interventions: Drug: androgel;   Drug: androgel 10g;   Drug: placebo
15 Not yet recruiting Effect of Testosterone on Endothelial Function and Microcirculation in Type 2 Diabetic Patients With Hypogonadism
Conditions: Type 2 Diabetes;   Hypogonadism
Intervention: Drug: Testosterone
16 Terminated A Pharmacokinetic (PK) Study to Compare the Absorption of Two Formulations of Transdermal Testosterone Spray and Intrinsa®
Condition: Hypoactive Sexual Desire Disorder
Interventions: Drug: Testosterone Spray 5% and 1%;   Drug: Intrinsa® Patch and Testosterone Spray 5%;   Drug: Intrinsa® Patch and Testosterone Spray 1%
17 Completed A Randomized Study of Testosterone Replacement in Patients With Low Risk Hormone Refractory Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: Androderm® 2.5mg;   Drug: Androderm® 5.0mg;   Drug: Androderm® 7.5mg
18 Completed Study On Bioavailability And Pharmacokinetics Of Various Doses Of Testosterone Administered With And Without Dutasteride
Condition: Hypogonadism
Interventions: Drug: Nanomilled testosterone;   Drug: commercially available dutasteride;   Drug: Nanomilled dutasteride
19 Suspended Vaginal Testosterone Cream For Atrophic Vaginitis in Women Taking Aromatase Inhibitors for Breast Cancer.
Conditions: Vaginitis;   Dyspareunia;   Breast Neoplasms
Intervention: Drug: Testosterone propionate
20 Completed Use of Nebido® to Assess Tolerability and Treatment Outcomes in Daily Clinical Practice
Conditions: Male;   Hypogonadism
Intervention: Drug: Testosterone Undecanoate (Nebido, BAY86-5037)

Previous Page Studies Shown (1-20) Next Page (21-40)
† Indicates status has not been verified in more than two years
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services